cnetsadmin

/cnetsadmin

About cnetsadmin

This author has not yet filled in any details.
So far cnetsadmin has created 25 blog entries.

ODB lists Afinitor (everolimus) for NETs of Gastrointestinal or Lung origin

We are pleased to announce that Ontario Drug Benefit (ODB) has listed Afinitor (everolimus) for the treatment of patients with GI/Lung NET, effective November 20, 2017 through the Exceptional Access [...]

By | November 24th, 2017|News|0 Comments

World NET Cancer Day a Success in Canada

On Friday, November 10th, 2017 – World NET Cancer Day, businesses and coffee shops around the world raised awareness about NETs using special coffee cups designed for the day. CNETS [...]

By | November 14th, 2017|Awareness|0 Comments

Diagnostic Scan – Ga68

The Gallium 68 scan, used with functional PET imaging, is a nuclear medicine scan that relies on the over-expression of somatostatin receptors to visualize tumours. NETs typically express several somatostatin receptor subtypes in [...]

By | October 4th, 2017|Treatment News|0 Comments

Somatuline (lanreotide) Access in Manitoba & Alberta

As we advised previously, in July of this year the Manitoba government issued a bulletin http://www.gov.mb.ca/health/mdbif/…/bulletins/bulletin93.pdf that indicated a change in the listing for Somatuline (from 1 to 3 and no access [...]

By | October 2nd, 2017|Treatment News|0 Comments

Caprelsa (vandetanib) for Medullary Thyroid NETs

Caprelsa is indicated for the treatment of symptomatic or progressive medullary thyroid cancer (MTC) in adult patients with unresectable locally advanced or metastatic disease.   An application for this drug was [...]

By | October 2nd, 2017|Treatment News|0 Comments

Afinitor (everolimus) for NETs of Gastrointestinal or Lung origin

Afinitor is currently paid for by provincial drug plans for patients with well-or moderately differentiated neuroendocrine tumours of pancreatic origin (pNET), in patients with unresectable, locally advanced or metastatic disease. [...]

By | October 2nd, 2017|Treatment News|0 Comments

Dr. Suzanne Richter

It is with profound sadness that we share the news of the passing of Dr. Suzanne Richter, Medical Oncologist on the NET team at London Health Sciences Centre.  This is [...]

By | April 4th, 2017|News|0 Comments

CCO to provide Ga68 Scan to Ontario patients

CCO to provide Ga-Octreotate to Ontario patients free of charge in Sherbrooke A message from Helena Senta: “At this time, CCO is proceeding with PET scan approval for the [...]

By | March 28th, 2017|Clinical Trial, Education, Treatment News|0 Comments

Thank you

Thank you to all our donors and volunteers! As we start anew into 2017, CNETS Canada would like to acknowledge and thank all our donors and volunteers for their generosity. [...]

By | February 15th, 2017|News|0 Comments

Campaign Shines Spotlight on Rare Cancer

Media Release Campaign Shines Spotlight on Rare Cancer on November 10th –World NET Cancer Day Toronto, ON – November 10th, 2016 – Today is World NET Cancer Day. To raise [...]

By | November 9th, 2016|Awareness, News|0 Comments